🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
There will be 2 phases in this study. Patients will either be enrolled to t...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
Start Date
2006-09
Trial ID
NCT00402116
Treatments Being Tested
Determine the doses and schedule appropriate for phase 2 study of sorafenib...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2015-01-29
Trial ID
NCT02349867
Primary Objective: 1\. To assess resectability rate in patients undergoing...
Status
Completed
Location
U.T. M.D. Anderson Cancer Center
Start Date
2006-06
Trial ID
NCT00336648
Treatments Being Tested
This is a phase II study of Bevacizumab plus Temodar and Tarceva in patient...
Status
Completed
Location
University of California San Francisco
Start Date
2007-09
Trial ID
NCT00525525
Treatments Being Tested
RATIONALE: Hormones can stimulate the growth of prostate cancer cells. Horm...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2000-02
Trial ID
NCT00005044
Treatments Being Tested
This randomized, open-label, multicenter, 2-arm study will investigate the ...
Status
Completed
Location
The Children's Hospital at Westmead
Start Date
2011-10-18
Trial ID
NCT01390948
Treatments Being Tested
NEEDS is a pragmatic open-label, randomised, controlled, phase III, multice...
Status
Recruiting
Location
McGill University Health Centre
Start Date
2020-11-27
Trial ID
NCT04460352
The purpose of this study is to establish the efficacy and toxicity of low ...
Status
Active Not Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2016-04-25
Trial ID
NCT02945631
In this multicenter trial, we plan to evaluate the feasibility and toxicity...
Status
Completed
Location
Multiple Locations
Start Date
2003-08
Trial ID
NCT00193375
Treatments Being Tested
This is a randomized multicentre study in patients with high-risk MIBC to i...
Status
Active Not Recruiting
Location
ICO Paul Papin
Start Date
2018-04-19
Trial ID
NCT03333356
Treatments Being Tested